Document is current

Article History

Received: 29 December 2017

Accepted: 15 March 2018

First Online: 19 April 2018

Ethics approval and consent to participate

: The trial has been approved by the Ethics Committees of the all participating sites in South Africa (Stellenbosch University and University of Cape Town Research Ethics Committees), Uganda (Joint Clinical Research Centre Institutional Review Board), Zambia (University of Zambia Biomedical Research Ethics Committee and National Health Research Ethics Committee), India (BJMC Ethics Committee-Pune, National Institute of Research in Tuberculosis Ethics Committee-Chennai and Health Ministry Screening Committee) and by University College London (UCL Research Ethics Committee). The study was also approved by the regulatory authorities in all the participating countries.Written informed consent (parents/caregivers) and assent (children whose understanding is considered adequate) will be obtained before any trial procedures are carried out and participants’ confidentiality will be maintained throughout the trial in line with the standard ICH-GCP principles.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.